PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Ecole nationale vétérinaire de Toulouse, ENVT, INRAE, UMR 1225, IHAP, Université de Toulouse, Toulouse, France.\', \'Nancy laboratory for rabies and wildlife, ANSES, Lyssavirus Unit, Malzéville, France.\', \'Nancy laboratory for rabies and wildlife, ANSES, Atton experimental facility, Atton, France.\', \'Ecole nationale vétérinaire de Toulouse, ENVT, CREFRE, INSERM, Université de Toulouse, Toulouse, France.\', \'National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.ppat.1009427
?:doi
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34370799
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
?:title
  • Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34370799>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34370799>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all